Abstract Submission Rules

1. Abstract Submission

  • All submissions must be made via the ICS website www.ics.org/2018/abstracts before 3rd April.
  • The ICS Scientific Committee will decide on the presentation category for presentation abstracts;
    • Podium Presentation
    • E-Poster
  • All accepted abstracts will be published on the ICS website exactly as submitted.
  • Podium Presentations will be published in Neurourology & Urodynamics.
    • View definitions of all presentation types at ICS Meetings

2. Anonymity for most objective review

  • The abstract text must be anonymous. i.e. without any authors’ or institutions’ names. Do not include the name of the hospital, university or city.
  • All abstract identification details, references, ethical approval, and disclosures will be taken separately as part of the online submission process and will be merged again with the abstract text after review.

3. Ethical approval

  • A clear statement on ethical approval must be given, or stated as NONE.
  • For studies in humans, ethical committee approval must be clearly identified and patients’ informed consent must be stated.
  • For studies in animals, conformity with institutional/national guidelines for the care and use of animals must be declared, and when applicable the animal ethics committee be identified.

4. Disclosures and funding

  • Any external funding of the study or grants must be declared or stated as NONE.

5. Abstract Formatting and Subtitles

  • The format requested are "extended abstracts" which must be at least 1 full page but not more than 2 full pages.
  • Do not use characters or symbols from any font set other than Arial.
  • Images, figures, graphs and tables can be included in the abstract.
  • Abstracts must use the sections given:
    • Hypothesis / aims of study
    • Study design, materials and methods
    • Results
    • Interpretation of results
    • Concluding message
      Missing sections will cause rejection.

6. Abstract Content

  • Abstracts must be written in English.
  • Abstracts previously published or presented at an international meeting, comparable to the ICS, are rejected.
  • All abstracts must contain adequate data. Case reports or study proposals only will not be accepted.
  • Strictly use ICS Terminology. Please note that the use of obsolete terminology may cause rejection. View current ICS Terminology reports.
  • For studies comparing results between groups, sample size (power) calculations must be included.
  • For RCTs any non-adherence to the CONSORT guidelines must be specified and justified.
  • Studies must not be split into multiple abstracts. This could lead to each abstract being downgraded.
  • Abstracts must specify either:
    • Basic Science / Translational
    • Clinical
  • Abstracts must specify one Broad Category (*=New for 2018):
Broad Categories
Anatomy / Biomechanics Overactive Bladder
Anorectal / Bowel Dysfunction Paediatrics
Conservative Management Pelvic Organ Prolapse
Continence Care Products / Devices / Technologies * Pelvic Pain Syndromes / Sexual Dysfunction
Ethics Pharmacology
Female Lower Urinary Tract Symptoms (LUTS) / Voiding Dysfunction Prevention and Public Health
Female Stress Urinary Incontinence (SUI) Prostatic Clinical/ Surgical *
Geriatrics / Gerontology Quality of Life / Patient and Caregiver Experiences *
Health Services Delivery Rehabilitation
Imaging Research Methods / Techniques
Male Lower Urinary Tract Symptoms (LUTS) / Incontinence Urethra Male and Female *
Neurourology Urodynamics
Nocturia
  • Abstracts must specify three Keywords but no more than five:
Keywords
Anal Incontinence Grafts: Synthetic Nursing Questionnaire
Anatomy Hormone Therapy Outcomes Research Methods Rehabilitation
Animal Study Imaging Overactive Bladder Retrospective Study
Basic Science Incontinence Pad Test Sensory Dysfunction
Benign Prostatic Hyperplasia (BPH) Infection, Urinary Tract Pain, Pelvic/Perineal Sexual Dysfunction
Biochemistry Infection, other Painful Bladder Syndrome/Interstitial Cystitis (IC) Spinal Cord Injury
Biomechanics Male Pain, other Stem Cells / Tissue Engineering
Bladder Outlet Obstruction Mathematical or statistical modelling Pathophysiology Stress Urinary Incontinence
Bowel Evacuation Dysfunction Mixed Urinary Incontinence Pediatrics Surgery
Cell Culture Molecular Biology Pelvic Floor Terminology
Clinical Trial Motor Dysfunction Pelvic Organ Prolapse Transgender
Conservative Treatment Multiple Sclerosis Pharmacology Underactive Bladder
Constipation New Instrumentation Physiotherapy Urgency Urinary Incontinence
Detrusor Overactivity New Devices Physiology Urgency, Fecal
Detrusor Hypocontractility Neuromodulation Pre-Clinical testing Urgency/Frequency
Female Neuropathies: Central Prevention Urodynamics Techniques
Fistulas Neuropathies: Peripheral Prolapse Symptoms Urodynamics Equipment
Gerontology Nocturia Prospective Study Voiding Diary
Grafts: Biological Nocturnal Enuresis Quality of Life (QoL) Voiding Dysfunction

7. Authors

  • First Authors (presenters) can only be first authors on a maximum of three submitted abstracts.

8. Abstract References

  • A maximum of 3 references must be listed separately, and referred to in the abstract text only with numbers in brackets.

9. Final Precautions

Abstract Title:

  • Title only; NO author or institution details.

Abstract Text:

  • Minimum 1 full page; maximum 2 pages, including tables and figures.
  • All subtitle sections filled adequately.
  • ICS-IUGA Standards in Terminology and guidelines adhered to.

Separately Submitted:

  • Ethical approval / Funding, - NOT in text.
  • Author and institution, - NOT in text.
  • References, ONLY numbers in brackets in text.

IF YOU VIOLATE ANY ABSTRACT SUBMISSION RULE, YOUR ABSTRACT WILL BE REJECTED

Register now